1. Home
  2. NXGL vs CTXR Comparison

NXGL vs CTXR Comparison

Compare NXGL & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXGL
  • CTXR
  • Stock Information
  • Founded
  • NXGL 1997
  • CTXR 2007
  • Country
  • NXGL United States
  • CTXR United States
  • Employees
  • NXGL N/A
  • CTXR N/A
  • Industry
  • NXGL Medical/Dental Instruments
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • NXGL Health Care
  • CTXR Health Care
  • Exchange
  • NXGL Nasdaq
  • CTXR Nasdaq
  • Market Cap
  • NXGL 19.7M
  • CTXR 21.6M
  • IPO Year
  • NXGL 2021
  • CTXR N/A
  • Fundamental
  • Price
  • NXGL $2.36
  • CTXR $1.67
  • Analyst Decision
  • NXGL
  • CTXR Strong Buy
  • Analyst Count
  • NXGL 0
  • CTXR 3
  • Target Price
  • NXGL N/A
  • CTXR $53.00
  • AVG Volume (30 Days)
  • NXGL 35.9K
  • CTXR 1.5M
  • Earning Date
  • NXGL 08-13-2025
  • CTXR 08-11-2025
  • Dividend Yield
  • NXGL N/A
  • CTXR N/A
  • EPS Growth
  • NXGL N/A
  • CTXR N/A
  • EPS
  • NXGL N/A
  • CTXR N/A
  • Revenue
  • NXGL $10,228,000.00
  • CTXR N/A
  • Revenue This Year
  • NXGL $52.35
  • CTXR N/A
  • Revenue Next Year
  • NXGL $42.38
  • CTXR N/A
  • P/E Ratio
  • NXGL N/A
  • CTXR N/A
  • Revenue Growth
  • NXGL 116.01
  • CTXR N/A
  • 52 Week Low
  • NXGL $2.10
  • CTXR $0.65
  • 52 Week High
  • NXGL $5.10
  • CTXR $26.25
  • Technical
  • Relative Strength Index (RSI)
  • NXGL 42.79
  • CTXR 56.18
  • Support Level
  • NXGL $2.26
  • CTXR $1.40
  • Resistance Level
  • NXGL $2.58
  • CTXR $1.67
  • Average True Range (ATR)
  • NXGL 0.17
  • CTXR 0.18
  • MACD
  • NXGL -0.03
  • CTXR -0.03
  • Stochastic Oscillator
  • NXGL 18.25
  • CTXR 36.90

About NXGL NexGel Inc

NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Share on Social Networks: